Global Gene Synthesis Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Gene Synthesis Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Gene synthesis is defined as the synthetic biology method used to engineer artificial genes within a laboratory setting. It has a vital role in synthetic biology and biotechnology and also it is a significant tool for various fields such as molecular engineering, vaccine development, gene therapy, and heterologous gene expression in recombinant DNA technology.

Market Overview:

The latest research study on the global Gene Synthesis market finds that the global Gene Synthesis market reached a value of USD 534.2 million in 2022. It’s expected that the market will achieve USD 1400.81 million by 2028, exhibiting a CAGR of 17.43% during the forecast period.

Assessment of the Overall Impact of COVID-19 on the Industry

Cell and gene therapies are booming in the pandemic, which is driving demand for synthetic DNA products typically produced and supplied by CDMOs. In recent years, the growing demand for fast, inexpensive and accurate gene synthesis has led numerous biotechnology companies to attempt to meet the demand. The demand has further increased with the COVID-19 pandemic, as many companies developing vaccines or treatments against COVID-19 require DNA as a starting material. As a result, many tests are performed to diagnose COVID-19 infection.

GenScript Biotech Corporation's life science research outsourcing has a long-term growth opportunity in 2020 due to COVID-19, with full-year company revenues of approximately $38.6 million related to COVID-19, including protein antigens, assay kits, antibodies, and nucleic acidbased assays, while COVID-19 has accelerated outsourcing services for pharmaceutical and biotechnology companies.

Region Overview:

From 2022-2027, North America is estimated to witness robust growth prospects.

Company Overview:

GenScript Biotech Corporation is one of the major players operating in the Gene Synthesis market, holding a share of 25.80% in 2021.

Genscript Biotech Corporation is a global biotech company. Genscript Biotech Corporation is a life sciences research and application service and product provider that applies its proprietary technology to various fields from basic life sciences research to translational biomedical development, industrial synthetic products, and cell therapeutic solutions.

GeneArt provides key technologies for Synthetic Biology projects for example for the construction of bacteria which produce complex biopolymers such as biofuels or organisms which degrade environmental toxins. Furthermore the company contributes key technologies necessary to develop and produce new therapeutics and vaccines. Customers also rely on GeneArt services to improve enzymes, such as the ones used as additives in detergents.

Segmentation Overview:

Among different product types, PCR based enzyme synthesis segment is anticipated to contribute the largest market share in 2027.

Application Overview:

By application, the Diagnosis segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Gene Synthesis market covered in Chapter 3:

Bioneer Corporation
Integrated DNA Technologies
SBS Genetech
OriGene Technologies
Bio Basic
Eurogentec
Genewiz
ATUM
GenScript Biotech Corporation
Eurofins Scientific
GeneArt (Thermo Fisher Scientific)

In Chapter 4 and Chapter 14.2, on the basis of types, the Gene Synthesis market from 2018 to 2029 is primarily split into:

Solid Phase Synthesis
Chip based DNA synthesis
PCR based enzyme synthesis

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Gene Synthesis market from 2018 to 2029 covers:

Research and Development
Diagnosis
Therapeutics

Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)